nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A2—Carmustine—malignant glioma	0.283	0.57	CbGbCtD
Rabeprazole—CYP3A4—Temozolomide—malignant glioma	0.214	0.43	CbGbCtD
Rabeprazole—Abnormal platelets—Temozolomide—malignant glioma	0.021	0.0646	CcSEcCtD
Rabeprazole—Platelet disorder—Temozolomide—malignant glioma	0.0167	0.0513	CcSEcCtD
Rabeprazole—Omeprazole—CYP2C18—malignant glioma	0.00515	0.522	CrCbGaD
Rabeprazole—Interstitial pneumonia—Temozolomide—malignant glioma	0.00501	0.0154	CcSEcCtD
Rabeprazole—Lansoprazole—CYP2C18—malignant glioma	0.00471	0.478	CrCbGaD
Rabeprazole—Cerebral haemorrhage—Carmustine—malignant glioma	0.00453	0.0139	CcSEcCtD
Rabeprazole—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00438	0.0135	CcSEcCtD
Rabeprazole—Embolism—Temozolomide—malignant glioma	0.00377	0.0116	CcSEcCtD
Rabeprazole—Tooth disorder—Temozolomide—malignant glioma	0.00374	0.0115	CcSEcCtD
Rabeprazole—Interstitial lung disease—Carmustine—malignant glioma	0.00354	0.0109	CcSEcCtD
Rabeprazole—Thrombosis—Carmustine—malignant glioma	0.00354	0.0109	CcSEcCtD
Rabeprazole—Interstitial lung disease—Temozolomide—malignant glioma	0.00342	0.0105	CcSEcCtD
Rabeprazole—Lung disorder—Temozolomide—malignant glioma	0.00342	0.0105	CcSEcCtD
Rabeprazole—Menorrhagia—Temozolomide—malignant glioma	0.00327	0.0101	CcSEcCtD
Rabeprazole—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00327	0.0101	CcSEcCtD
Rabeprazole—Herpes zoster—Temozolomide—malignant glioma	0.00322	0.00989	CcSEcCtD
Rabeprazole—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00322	0.00989	CcSEcCtD
Rabeprazole—Abscess—Carmustine—malignant glioma	0.00317	0.00974	CcSEcCtD
Rabeprazole—Otitis media—Temozolomide—malignant glioma	0.00311	0.00957	CcSEcCtD
Rabeprazole—Injection site pain—Carmustine—malignant glioma	0.00307	0.00944	CcSEcCtD
Rabeprazole—Breast pain—Temozolomide—malignant glioma	0.00278	0.00854	CcSEcCtD
Rabeprazole—Leukocytosis—Carmustine—malignant glioma	0.00267	0.0082	CcSEcCtD
Rabeprazole—Herpes simplex—Temozolomide—malignant glioma	0.00263	0.00808	CcSEcCtD
Rabeprazole—Neck pain—Carmustine—malignant glioma	0.00254	0.0078	CcSEcCtD
Rabeprazole—Pulmonary embolism—Carmustine—malignant glioma	0.00251	0.00771	CcSEcCtD
Rabeprazole—Injection site reaction—Carmustine—malignant glioma	0.00249	0.00766	CcSEcCtD
Rabeprazole—Respiratory failure—Temozolomide—malignant glioma	0.00247	0.00758	CcSEcCtD
Rabeprazole—Pulmonary embolism—Temozolomide—malignant glioma	0.00242	0.00745	CcSEcCtD
Rabeprazole—Vaginal inflammation—Temozolomide—malignant glioma	0.00242	0.00745	CcSEcCtD
Rabeprazole—Urinary incontinence—Carmustine—malignant glioma	0.00242	0.00744	CcSEcCtD
Rabeprazole—Candida infection—Carmustine—malignant glioma	0.00239	0.00736	CcSEcCtD
Rabeprazole—Neuropathy—Carmustine—malignant glioma	0.00235	0.00723	CcSEcCtD
Rabeprazole—Urinary incontinence—Temozolomide—malignant glioma	0.00234	0.00719	CcSEcCtD
Rabeprazole—Candida infection—Temozolomide—malignant glioma	0.00231	0.00711	CcSEcCtD
Rabeprazole—Coma—Carmustine—malignant glioma	0.00229	0.00704	CcSEcCtD
Rabeprazole—Vaginal infection—Temozolomide—malignant glioma	0.00229	0.00703	CcSEcCtD
Rabeprazole—Neuropathy—Temozolomide—malignant glioma	0.00228	0.00699	CcSEcCtD
Rabeprazole—Neoplasm—Carmustine—malignant glioma	0.00227	0.00697	CcSEcCtD
Rabeprazole—Gynaecomastia—Carmustine—malignant glioma	0.00224	0.00689	CcSEcCtD
Rabeprazole—Dry eye—Temozolomide—malignant glioma	0.00224	0.00688	CcSEcCtD
Rabeprazole—Neoplasm—Temozolomide—malignant glioma	0.00219	0.00673	CcSEcCtD
Rabeprazole—Abnormal vision—Carmustine—malignant glioma	0.00219	0.00672	CcSEcCtD
Rabeprazole—Abnormal vision—Temozolomide—malignant glioma	0.00211	0.00649	CcSEcCtD
Rabeprazole—Thrombophlebitis—Carmustine—malignant glioma	0.0021	0.00646	CcSEcCtD
Rabeprazole—Diabetes mellitus—Carmustine—malignant glioma	0.00209	0.00643	CcSEcCtD
Rabeprazole—Ear pain—Temozolomide—malignant glioma	0.00206	0.00634	CcSEcCtD
Rabeprazole—Thrombophlebitis—Temozolomide—malignant glioma	0.00203	0.00624	CcSEcCtD
Rabeprazole—Eye pain—Carmustine—malignant glioma	0.00202	0.0062	CcSEcCtD
Rabeprazole—Gastroenteritis—Temozolomide—malignant glioma	0.00198	0.0061	CcSEcCtD
Rabeprazole—Deafness—Temozolomide—malignant glioma	0.00197	0.00604	CcSEcCtD
Rabeprazole—Eye pain—Temozolomide—malignant glioma	0.00195	0.00599	CcSEcCtD
Rabeprazole—Amnesia—Carmustine—malignant glioma	0.00194	0.00595	CcSEcCtD
Rabeprazole—Amnesia—Temozolomide—malignant glioma	0.00187	0.00575	CcSEcCtD
Rabeprazole—Thirst—Temozolomide—malignant glioma	0.00185	0.00568	CcSEcCtD
Rabeprazole—Hyponatraemia—Carmustine—malignant glioma	0.00183	0.00562	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00182	0.00559	CcSEcCtD
Rabeprazole—Diplopia—Carmustine—malignant glioma	0.00182	0.00559	CcSEcCtD
Rabeprazole—Diplopia—Temozolomide—malignant glioma	0.00176	0.00541	CcSEcCtD
Rabeprazole—Face oedema—Carmustine—malignant glioma	0.00176	0.0054	CcSEcCtD
Rabeprazole—Face oedema—Temozolomide—malignant glioma	0.0017	0.00522	CcSEcCtD
Rabeprazole—Liver function test abnormal—Carmustine—malignant glioma	0.00168	0.00516	CcSEcCtD
Rabeprazole—Hypokalaemia—Carmustine—malignant glioma	0.00166	0.00509	CcSEcCtD
Rabeprazole—Dehydration—Temozolomide—malignant glioma	0.00164	0.00503	CcSEcCtD
Rabeprazole—Dry skin—Temozolomide—malignant glioma	0.00161	0.00495	CcSEcCtD
Rabeprazole—Hypokalaemia—Temozolomide—malignant glioma	0.0016	0.00492	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00158	0.00487	CcSEcCtD
Rabeprazole—Dysphagia—Carmustine—malignant glioma	0.00157	0.00483	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00155	0.00477	CcSEcCtD
Rabeprazole—Abdominal distension—Temozolomide—malignant glioma	0.00153	0.0047	CcSEcCtD
Rabeprazole—Dysphagia—Temozolomide—malignant glioma	0.00152	0.00467	CcSEcCtD
Rabeprazole—Pancytopenia—Carmustine—malignant glioma	0.00149	0.00459	CcSEcCtD
Rabeprazole—Neutropenia—Carmustine—malignant glioma	0.00147	0.00452	CcSEcCtD
Rabeprazole—Bronchitis—Temozolomide—malignant glioma	0.00146	0.00449	CcSEcCtD
Rabeprazole—Pancytopenia—Temozolomide—malignant glioma	0.00144	0.00444	CcSEcCtD
Rabeprazole—Dysuria—Temozolomide—malignant glioma	0.00142	0.00437	CcSEcCtD
Rabeprazole—Neutropenia—Temozolomide—malignant glioma	0.00142	0.00437	CcSEcCtD
Rabeprazole—Hyperglycaemia—Carmustine—malignant glioma	0.00142	0.00436	CcSEcCtD
Rabeprazole—Pneumonia—Carmustine—malignant glioma	0.00141	0.00434	CcSEcCtD
Rabeprazole—Pollakiuria—Temozolomide—malignant glioma	0.0014	0.00432	CcSEcCtD
Rabeprazole—Erectile dysfunction—Temozolomide—malignant glioma	0.0014	0.0043	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Temozolomide—malignant glioma	0.00139	0.00426	CcSEcCtD
Rabeprazole—Weight increased—Temozolomide—malignant glioma	0.00138	0.00425	CcSEcCtD
Rabeprazole—Weight decreased—Temozolomide—malignant glioma	0.00138	0.00423	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Carmustine—malignant glioma	0.00138	0.00423	CcSEcCtD
Rabeprazole—Hyperglycaemia—Temozolomide—malignant glioma	0.00137	0.00421	CcSEcCtD
Rabeprazole—Stomatitis—Carmustine—malignant glioma	0.00137	0.0042	CcSEcCtD
Rabeprazole—Urinary tract infection—Carmustine—malignant glioma	0.00136	0.00419	CcSEcCtD
Rabeprazole—Pneumonia—Temozolomide—malignant glioma	0.00136	0.00419	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00134	0.00413	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Temozolomide—malignant glioma	0.00133	0.00408	CcSEcCtD
Rabeprazole—Stomatitis—Temozolomide—malignant glioma	0.00132	0.00406	CcSEcCtD
Rabeprazole—Urinary tract infection—Temozolomide—malignant glioma	0.00132	0.00405	CcSEcCtD
Rabeprazole—Sinusitis—Temozolomide—malignant glioma	0.00127	0.00391	CcSEcCtD
Rabeprazole—Oedema peripheral—Carmustine—malignant glioma	0.00124	0.00381	CcSEcCtD
Rabeprazole—Hepatitis—Temozolomide—malignant glioma	0.00122	0.00374	CcSEcCtD
Rabeprazole—Visual impairment—Carmustine—malignant glioma	0.00121	0.00373	CcSEcCtD
Rabeprazole—Pharyngitis—Temozolomide—malignant glioma	0.00121	0.00371	CcSEcCtD
Rabeprazole—Urinary tract disorder—Temozolomide—malignant glioma	0.0012	0.00369	CcSEcCtD
Rabeprazole—Oedema peripheral—Temozolomide—malignant glioma	0.0012	0.00368	CcSEcCtD
Rabeprazole—Urethral disorder—Temozolomide—malignant glioma	0.00119	0.00367	CcSEcCtD
Rabeprazole—Eye disorder—Carmustine—malignant glioma	0.00118	0.00362	CcSEcCtD
Rabeprazole—Visual impairment—Temozolomide—malignant glioma	0.00117	0.0036	CcSEcCtD
Rabeprazole—Erythema multiforme—Temozolomide—malignant glioma	0.00115	0.00354	CcSEcCtD
Rabeprazole—Eye disorder—Temozolomide—malignant glioma	0.00114	0.00349	CcSEcCtD
Rabeprazole—Tinnitus—Temozolomide—malignant glioma	0.00113	0.00349	CcSEcCtD
Rabeprazole—Arrhythmia—Carmustine—malignant glioma	0.00112	0.00346	CcSEcCtD
Rabeprazole—Alopecia—Carmustine—malignant glioma	0.00111	0.00342	CcSEcCtD
Rabeprazole—Angiopathy—Temozolomide—malignant glioma	0.0011	0.00339	CcSEcCtD
Rabeprazole—Malnutrition—Carmustine—malignant glioma	0.0011	0.00337	CcSEcCtD
Rabeprazole—Erythema—Carmustine—malignant glioma	0.0011	0.00337	CcSEcCtD
Rabeprazole—Chills—Temozolomide—malignant glioma	0.00109	0.00336	CcSEcCtD
Rabeprazole—Alopecia—Temozolomide—malignant glioma	0.00108	0.0033	CcSEcCtD
Rabeprazole—Back pain—Carmustine—malignant glioma	0.00106	0.00326	CcSEcCtD
Rabeprazole—Malnutrition—Temozolomide—malignant glioma	0.00106	0.00326	CcSEcCtD
Rabeprazole—Erythema—Temozolomide—malignant glioma	0.00106	0.00326	CcSEcCtD
Rabeprazole—Dysgeusia—Temozolomide—malignant glioma	0.00104	0.00319	CcSEcCtD
Rabeprazole—Vision blurred—Carmustine—malignant glioma	0.00103	0.00317	CcSEcCtD
Rabeprazole—Tremor—Carmustine—malignant glioma	0.00103	0.00316	CcSEcCtD
Rabeprazole—Back pain—Temozolomide—malignant glioma	0.00102	0.00315	CcSEcCtD
Rabeprazole—Anaemia—Carmustine—malignant glioma	0.00101	0.00311	CcSEcCtD
Rabeprazole—Agitation—Carmustine—malignant glioma	0.00101	0.0031	CcSEcCtD
Rabeprazole—Vision blurred—Temozolomide—malignant glioma	0.000998	0.00307	CcSEcCtD
Rabeprazole—Tremor—Temozolomide—malignant glioma	0.000992	0.00305	CcSEcCtD
Rabeprazole—Ill-defined disorder—Temozolomide—malignant glioma	0.000983	0.00302	CcSEcCtD
Rabeprazole—Leukopenia—Carmustine—malignant glioma	0.000981	0.00302	CcSEcCtD
Rabeprazole—Anaemia—Temozolomide—malignant glioma	0.000979	0.00301	CcSEcCtD
Rabeprazole—Agitation—Temozolomide—malignant glioma	0.000974	0.00299	CcSEcCtD
Rabeprazole—Angioedema—Temozolomide—malignant glioma	0.000968	0.00297	CcSEcCtD
Rabeprazole—Malaise—Temozolomide—malignant glioma	0.000955	0.00294	CcSEcCtD
Rabeprazole—Vertigo—Temozolomide—malignant glioma	0.000952	0.00292	CcSEcCtD
Rabeprazole—Convulsion—Carmustine—malignant glioma	0.00095	0.00292	CcSEcCtD
Rabeprazole—Leukopenia—Temozolomide—malignant glioma	0.000948	0.00291	CcSEcCtD
Rabeprazole—Hypertension—Carmustine—malignant glioma	0.000946	0.00291	CcSEcCtD
Rabeprazole—Palpitations—Temozolomide—malignant glioma	0.000936	0.00288	CcSEcCtD
Rabeprazole—Myalgia—Carmustine—malignant glioma	0.000933	0.00287	CcSEcCtD
Rabeprazole—Chest pain—Carmustine—malignant glioma	0.000933	0.00287	CcSEcCtD
Rabeprazole—Anxiety—Carmustine—malignant glioma	0.00093	0.00286	CcSEcCtD
Rabeprazole—Cough—Temozolomide—malignant glioma	0.000924	0.00284	CcSEcCtD
Rabeprazole—Convulsion—Temozolomide—malignant glioma	0.000918	0.00282	CcSEcCtD
Rabeprazole—Hypertension—Temozolomide—malignant glioma	0.000915	0.00281	CcSEcCtD
Rabeprazole—Confusional state—Carmustine—malignant glioma	0.000902	0.00277	CcSEcCtD
Rabeprazole—Arthralgia—Temozolomide—malignant glioma	0.000902	0.00277	CcSEcCtD
Rabeprazole—Myalgia—Temozolomide—malignant glioma	0.000902	0.00277	CcSEcCtD
Rabeprazole—Anxiety—Temozolomide—malignant glioma	0.000899	0.00276	CcSEcCtD
Rabeprazole—Oedema—Carmustine—malignant glioma	0.000895	0.00275	CcSEcCtD
Rabeprazole—Discomfort—Temozolomide—malignant glioma	0.000891	0.00274	CcSEcCtD
Rabeprazole—Dry mouth—Temozolomide—malignant glioma	0.000882	0.00271	CcSEcCtD
Rabeprazole—Thrombocytopenia—Carmustine—malignant glioma	0.000876	0.00269	CcSEcCtD
Rabeprazole—Tachycardia—Carmustine—malignant glioma	0.000873	0.00268	CcSEcCtD
Rabeprazole—Confusional state—Temozolomide—malignant glioma	0.000872	0.00268	CcSEcCtD
Rabeprazole—Oedema—Temozolomide—malignant glioma	0.000865	0.00266	CcSEcCtD
Rabeprazole—Anaphylactic shock—Temozolomide—malignant glioma	0.000865	0.00266	CcSEcCtD
Rabeprazole—Anorexia—Carmustine—malignant glioma	0.000853	0.00262	CcSEcCtD
Rabeprazole—Thrombocytopenia—Temozolomide—malignant glioma	0.000847	0.0026	CcSEcCtD
Rabeprazole—Hypotension—Carmustine—malignant glioma	0.000836	0.00257	CcSEcCtD
Rabeprazole—Hyperhidrosis—Temozolomide—malignant glioma	0.000836	0.00257	CcSEcCtD
Rabeprazole—Anorexia—Temozolomide—malignant glioma	0.000824	0.00253	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000815	0.0025	CcSEcCtD
Rabeprazole—Insomnia—Carmustine—malignant glioma	0.000809	0.00249	CcSEcCtD
Rabeprazole—Paraesthesia—Carmustine—malignant glioma	0.000803	0.00247	CcSEcCtD
Rabeprazole—Dyspnoea—Carmustine—malignant glioma	0.000798	0.00245	CcSEcCtD
Rabeprazole—Somnolence—Carmustine—malignant glioma	0.000795	0.00244	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000788	0.00242	CcSEcCtD
Rabeprazole—Insomnia—Temozolomide—malignant glioma	0.000782	0.0024	CcSEcCtD
Rabeprazole—Decreased appetite—Carmustine—malignant glioma	0.000778	0.00239	CcSEcCtD
Rabeprazole—Paraesthesia—Temozolomide—malignant glioma	0.000776	0.00239	CcSEcCtD
Rabeprazole—Dyspnoea—Temozolomide—malignant glioma	0.000771	0.00237	CcSEcCtD
Rabeprazole—Somnolence—Temozolomide—malignant glioma	0.000769	0.00236	CcSEcCtD
Rabeprazole—Pain—Carmustine—malignant glioma	0.000765	0.00235	CcSEcCtD
Rabeprazole—Constipation—Carmustine—malignant glioma	0.000765	0.00235	CcSEcCtD
Rabeprazole—Dyspepsia—Temozolomide—malignant glioma	0.000761	0.00234	CcSEcCtD
Rabeprazole—Decreased appetite—Temozolomide—malignant glioma	0.000752	0.00231	CcSEcCtD
Rabeprazole—Pain—Temozolomide—malignant glioma	0.000739	0.00227	CcSEcCtD
Rabeprazole—Constipation—Temozolomide—malignant glioma	0.000739	0.00227	CcSEcCtD
Rabeprazole—Feeling abnormal—Carmustine—malignant glioma	0.000737	0.00227	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Carmustine—malignant glioma	0.000732	0.00225	CcSEcCtD
Rabeprazole—Feeling abnormal—Temozolomide—malignant glioma	0.000712	0.00219	CcSEcCtD
Rabeprazole—Abdominal pain—Carmustine—malignant glioma	0.000707	0.00217	CcSEcCtD
Rabeprazole—Body temperature increased—Carmustine—malignant glioma	0.000707	0.00217	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000707	0.00217	CcSEcCtD
Rabeprazole—Urticaria—Temozolomide—malignant glioma	0.000687	0.00211	CcSEcCtD
Rabeprazole—Abdominal pain—Temozolomide—malignant glioma	0.000683	0.0021	CcSEcCtD
Rabeprazole—Body temperature increased—Temozolomide—malignant glioma	0.000683	0.0021	CcSEcCtD
Rabeprazole—Hypersensitivity—Carmustine—malignant glioma	0.000659	0.00203	CcSEcCtD
Rabeprazole—Asthenia—Carmustine—malignant glioma	0.000642	0.00197	CcSEcCtD
Rabeprazole—Hypersensitivity—Temozolomide—malignant glioma	0.000637	0.00196	CcSEcCtD
Rabeprazole—Asthenia—Temozolomide—malignant glioma	0.00062	0.00191	CcSEcCtD
Rabeprazole—Diarrhoea—Carmustine—malignant glioma	0.000612	0.00188	CcSEcCtD
Rabeprazole—Pruritus—Temozolomide—malignant glioma	0.000612	0.00188	CcSEcCtD
Rabeprazole—Dizziness—Carmustine—malignant glioma	0.000592	0.00182	CcSEcCtD
Rabeprazole—Diarrhoea—Temozolomide—malignant glioma	0.000592	0.00182	CcSEcCtD
Rabeprazole—Dizziness—Temozolomide—malignant glioma	0.000572	0.00176	CcSEcCtD
Rabeprazole—Vomiting—Carmustine—malignant glioma	0.000569	0.00175	CcSEcCtD
Rabeprazole—Rash—Carmustine—malignant glioma	0.000564	0.00173	CcSEcCtD
Rabeprazole—Dermatitis—Carmustine—malignant glioma	0.000564	0.00173	CcSEcCtD
Rabeprazole—Headache—Carmustine—malignant glioma	0.00056	0.00172	CcSEcCtD
Rabeprazole—Vomiting—Temozolomide—malignant glioma	0.00055	0.00169	CcSEcCtD
Rabeprazole—Rash—Temozolomide—malignant glioma	0.000545	0.00168	CcSEcCtD
Rabeprazole—Dermatitis—Temozolomide—malignant glioma	0.000545	0.00167	CcSEcCtD
Rabeprazole—Headache—Temozolomide—malignant glioma	0.000542	0.00166	CcSEcCtD
Rabeprazole—Nausea—Carmustine—malignant glioma	0.000531	0.00163	CcSEcCtD
Rabeprazole—Nausea—Temozolomide—malignant glioma	0.000514	0.00158	CcSEcCtD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.00013	0.000777	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—RTEL1—malignant glioma	0.00013	0.000777	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000129	0.000768	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000127	0.000758	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—RTEL1—malignant glioma	0.00012	0.000714	CbGpPWpGaD
Rabeprazole—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.00012	0.000713	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000119	0.000708	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000119	0.000707	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000118	0.000702	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000118	0.0007	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000117	0.000697	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000116	0.000691	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ASMT—malignant glioma	0.000115	0.000685	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000115	0.000685	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000114	0.000678	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000112	0.000666	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00011	0.000656	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000108	0.000645	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—BCAN—malignant glioma	0.000108	0.000644	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000106	0.000631	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000106	0.000631	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000106	0.000629	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000105	0.000625	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—RTEL1—malignant glioma	0.000102	0.000605	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000101	0.000601	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000101	0.000601	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.0001	0.000599	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.0001	0.000598	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.0001	0.000596	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.0001	0.000596	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	9.91e-05	0.00059	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.32e-05	0.000555	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—COX8A—malignant glioma	9.15e-05	0.000545	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.02e-05	0.000537	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—IDH2—malignant glioma	8.71e-05	0.000519	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.5e-05	0.000506	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.22e-05	0.00049	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP2B6—malignant glioma	8.19e-05	0.000488	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.18e-05	0.000487	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—RTEL1—malignant glioma	7.84e-05	0.000467	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ASMT—malignant glioma	7.78e-05	0.000464	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.75e-05	0.000462	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	7.65e-05	0.000456	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.6e-05	0.000453	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—IDH1—malignant glioma	7.49e-05	0.000446	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—COX8A—malignant glioma	7.49e-05	0.000446	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—BCAN—malignant glioma	7.32e-05	0.000436	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.26e-05	0.000433	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SPHK1—malignant glioma	7.25e-05	0.000432	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP2C18—malignant glioma	7.1e-05	0.000423	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.03e-05	0.000419	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—COX8A—malignant glioma	6.89e-05	0.00041	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—COX8A—malignant glioma	6.83e-05	0.000407	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.69e-05	0.000399	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ASMT—malignant glioma	6.37e-05	0.000379	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.22e-05	0.000371	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.1e-05	0.000364	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—BCAN—malignant glioma	5.99e-05	0.000357	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—IDH2—malignant glioma	5.9e-05	0.000351	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ASMT—malignant glioma	5.86e-05	0.000349	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—COX8A—malignant glioma	5.83e-05	0.000348	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ASMT—malignant glioma	5.81e-05	0.000346	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTT1—malignant glioma	5.74e-05	0.000342	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.67e-05	0.000338	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.56e-05	0.000331	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP2B6—malignant glioma	5.54e-05	0.00033	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BCAN—malignant glioma	5.51e-05	0.000328	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BCAN—malignant glioma	5.46e-05	0.000325	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS1—malignant glioma	5.38e-05	0.000321	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.22e-05	0.000311	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—IDH1—malignant glioma	5.07e-05	0.000302	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—BCHE—malignant glioma	5e-05	0.000298	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ASMT—malignant glioma	4.96e-05	0.000296	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SLC5A5—malignant glioma	4.94e-05	0.000294	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SPHK1—malignant glioma	4.91e-05	0.000292	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.85e-05	0.000289	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—IDH2—malignant glioma	4.83e-05	0.000287	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP2C18—malignant glioma	4.81e-05	0.000286	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BCAN—malignant glioma	4.66e-05	0.000278	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	4.55e-05	0.000271	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.55e-05	0.000271	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2B6—malignant glioma	4.54e-05	0.00027	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.53e-05	0.00027	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—COX8A—malignant glioma	4.5e-05	0.000268	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—IDH2—malignant glioma	4.44e-05	0.000264	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—IDH2—malignant glioma	4.4e-05	0.000262	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.17e-05	0.000249	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—IDH1—malignant glioma	4.15e-05	0.000247	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.15e-05	0.000247	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.14e-05	0.000246	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.13e-05	0.000246	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SPHK1—malignant glioma	4.02e-05	0.000239	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.98e-05	0.000237	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTP1—malignant glioma	3.98e-05	0.000237	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2C18—malignant glioma	3.93e-05	0.000234	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTT1—malignant glioma	3.89e-05	0.000232	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CAT—malignant glioma	3.87e-05	0.000231	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ASMT—malignant glioma	3.83e-05	0.000228	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—IDH1—malignant glioma	3.82e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—IDH1—malignant glioma	3.78e-05	0.000225	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—IDH2—malignant glioma	3.76e-05	0.000224	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.71e-05	0.000221	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SPHK1—malignant glioma	3.69e-05	0.00022	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SPHK1—malignant glioma	3.66e-05	0.000218	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NCOR1—malignant glioma	3.66e-05	0.000218	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS1—malignant glioma	3.64e-05	0.000217	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.63e-05	0.000216	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.62e-05	0.000216	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BCAN—malignant glioma	3.6e-05	0.000214	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.59e-05	0.000214	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.55e-05	0.000211	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.54e-05	0.000211	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—BCHE—malignant glioma	3.39e-05	0.000202	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.38e-05	0.000201	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.38e-05	0.000201	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC5A5—malignant glioma	3.35e-05	0.000199	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.26e-05	0.000194	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—IDH1—malignant glioma	3.23e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTT1—malignant glioma	3.18e-05	0.00019	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.16e-05	0.000188	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.13e-05	0.000187	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SPHK1—malignant glioma	3.13e-05	0.000186	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.08e-05	0.000184	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.07e-05	0.000183	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CAV1—malignant glioma	2.98e-05	0.000178	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS1—malignant glioma	2.98e-05	0.000178	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.97e-05	0.000177	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.97e-05	0.000177	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTT1—malignant glioma	2.93e-05	0.000174	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—IDH2—malignant glioma	2.9e-05	0.000173	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTT1—malignant glioma	2.9e-05	0.000173	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.89e-05	0.000172	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—BCHE—malignant glioma	2.77e-05	0.000165	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS1—malignant glioma	2.74e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.74e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.73e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.73e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS1—malignant glioma	2.72e-05	0.000162	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CG—malignant glioma	2.72e-05	0.000162	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.71e-05	0.000161	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTP1—malignant glioma	2.69e-05	0.000161	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.63e-05	0.000157	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAT—malignant glioma	2.62e-05	0.000156	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARG—malignant glioma	2.62e-05	0.000156	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.59e-05	0.000154	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.57e-05	0.000153	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BCHE—malignant glioma	2.55e-05	0.000152	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.54e-05	0.000151	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BCHE—malignant glioma	2.53e-05	0.000151	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.52e-05	0.00015	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.5e-05	0.000149	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—IDH1—malignant glioma	2.5e-05	0.000149	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—malignant glioma	2.48e-05	0.000148	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NCOR1—malignant glioma	2.48e-05	0.000148	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SPHK1—malignant glioma	2.41e-05	0.000144	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—malignant glioma	2.39e-05	0.000142	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.37e-05	0.000141	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.36e-05	0.000141	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.34e-05	0.000139	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS1—malignant glioma	2.32e-05	0.000138	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.31e-05	0.000138	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.24e-05	0.000133	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—malignant glioma	2.21e-05	0.000131	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BCHE—malignant glioma	2.16e-05	0.000129	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAT—malignant glioma	2.15e-05	0.000128	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.13e-05	0.000127	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—malignant glioma	2.08e-05	0.000124	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—malignant glioma	2.06e-05	0.000123	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.04e-05	0.000122	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—malignant glioma	2.03e-05	0.000121	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NCOR1—malignant glioma	2.03e-05	0.000121	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CAV1—malignant glioma	2.02e-05	0.00012	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.02e-05	0.00012	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—malignant glioma	2.01e-05	0.00012	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2e-05	0.000119	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAT—malignant glioma	1.97e-05	0.000118	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAT—malignant glioma	1.96e-05	0.000117	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.93e-05	0.000115	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—malignant glioma	1.91e-05	0.000114	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOR1—malignant glioma	1.86e-05	0.000111	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOR1—malignant glioma	1.85e-05	0.00011	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—malignant glioma	1.84e-05	0.00011	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—malignant glioma	1.8e-05	0.000107	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS1—malignant glioma	1.79e-05	0.000107	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARG—malignant glioma	1.77e-05	0.000106	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.74e-05	0.000104	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—malignant glioma	1.72e-05	0.000102	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAT—malignant glioma	1.67e-05	9.96e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BCHE—malignant glioma	1.67e-05	9.93e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CAV1—malignant glioma	1.65e-05	9.84e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.65e-05	9.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.62e-05	9.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOR1—malignant glioma	1.58e-05	9.41e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.58e-05	9.4e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CAV1—malignant glioma	1.52e-05	9.05e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CAV1—malignant glioma	1.51e-05	8.97e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.5e-05	8.96e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARG—malignant glioma	1.45e-05	8.65e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.44e-05	8.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.41e-05	8.39e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—malignant glioma	1.4e-05	8.32e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.38e-05	8.25e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.37e-05	8.17e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARG—malignant glioma	1.34e-05	7.96e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—malignant glioma	1.33e-05	7.9e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARG—malignant glioma	1.32e-05	7.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.32e-05	7.88e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAT—malignant glioma	1.29e-05	7.69e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CAV1—malignant glioma	1.29e-05	7.67e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—malignant glioma	1.27e-05	7.56e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.23e-05	7.33e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOR1—malignant glioma	1.22e-05	7.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—malignant glioma	1.22e-05	7.25e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.22e-05	7.25e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.21e-05	7.19e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.17e-05	6.98e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.15e-05	6.87e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—malignant glioma	1.14e-05	6.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARG—malignant glioma	1.13e-05	6.74e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.06e-05	6.32e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.05e-05	6.26e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—malignant glioma	1.05e-05	6.26e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—malignant glioma	1.04e-05	6.21e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—malignant glioma	1.04e-05	6.18e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.03e-05	6.14e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—malignant glioma	9.96e-06	5.94e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CAV1—malignant glioma	9.93e-06	5.92e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—malignant glioma	9.16e-06	5.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—malignant glioma	9.08e-06	5.41e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.05e-06	5.39e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.98e-06	5.35e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—malignant glioma	8.9e-06	5.3e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARG—malignant glioma	8.73e-06	5.2e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—malignant glioma	8.59e-06	5.12e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.95e-06	4.74e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—malignant glioma	7.76e-06	4.62e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—malignant glioma	7.03e-06	4.19e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—malignant glioma	7.02e-06	4.18e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.93e-06	4.13e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—malignant glioma	6.87e-06	4.09e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—malignant glioma	6.46e-06	3.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.41e-06	3.82e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—malignant glioma	5.99e-06	3.57e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—malignant glioma	5.74e-06	3.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.48e-06	3.26e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—malignant glioma	5.28e-06	3.15e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—malignant glioma	5.24e-06	3.12e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—malignant glioma	4.47e-06	2.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.23e-06	2.52e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—malignant glioma	3.45e-06	2.06e-05	CbGpPWpGaD
